Exact Mass: 420.0109

Exact Mass Matches: 420.0109

Found 96 metabolites which its exact mass value is equals to given mass value 420.0109, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Inositol 1,3,4-trisphosphate

(2,3,5-Trihydroxy-4,6-diphosphonooxycyclohexyl) dihydrogen phosphate

C6H15O15P3 (419.9624)


Inositol 1,3,4-trisphosphate (CAS: 98102-63-7), also known as Ins(1,3,4)P3 or I3S, belongs to the class of organic compounds known as inositol phosphates. Inositol phosphates are compounds containing a phosphate group attached to an inositol (or cyclohexanehexol) moiety. Within humans, inositol 1,3,4-trisphosphate participates in several enzymatic reactions. In particular, inositol 1,3,4-trisphosphate can be converted into 1D-myo-inositol 1,3,4,6-tetrakisphosphate through the action of the enzyme inositol-tetrakisphosphate 1-kinase. In addition, inositol 1,3,4-trisphosphate can be converted into inositol 1,3,4,5-tetraphosphate through its interaction with the enzyme inositol-tetrakisphosphate 1-kinase. In humans, inositol 1,3,4-trisphosphate is involved in inositol metabolism. Inositol 1,3,4-trisphosphate is a specific regulator of cellular signalling. A specific regulator of cellular signaling [HMDB]

   

myo-Inositol 1,4,5-trisphosphate

{[(1R,2S,3R,4R,5S,6R)-2,3,5-trihydroxy-4,6-bis(phosphonooxy)cyclohexyl]oxy}phosphonic acid

C6H15O15P3 (419.9624)


myo-Inositol 1,4,5-trisphosphate (CAS: 20298-95-7), also known as Ins(1,4,5)P3 or InsP3, is an intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane (PMID: 22453946). It is released into the cytoplasm where it releases calcium ions from internal stores within the cells endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin (PMID: 15189149). Its transient accumulation is due both to the enhanced metabolism via the Ca2+-calmodulin-sensitive Ins(1,4,5)P3 kinase, as well as a down-regulation of phosphatidylinositol 4,5-bisphosphate hydrolysis (PMID: 3041962). It is a major regulator of apoptotic signalling driving calcium (Ca2+) transients from the endoplasmic reticulum to mitochondria, thereby establishing a functional and physical link between these organelles. It also regulates autophagy through the interaction with Beclin 1 complex, and in particular, its inhibition/depletion strongly induces macroautophagy (PMID: 19325567). In addition, recent evidence suggests that the penetrating sperm delivers into mammalian eggs a novel isoform of phospholipase C (PLC), which promotes the formation of inositol 1,4,5-trisphosphate (PMID: 15362223). Intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane. Inositol 1,4,5-trisphosphate is released into the cytoplasm where it releases calcium ions from internal stores within the cells endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin. (PubChem)

   

(2,6-dihydroxy-4-{4-hydroxy-7-methyl-11-oxo-2,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),3,5(13),6,9-pentaen-3-yl}phenoxy)dihydroxyoxo-λ⁶-sulfanylium

(2,6-Dihydroxy-4-{4-hydroxy-7-methyl-11-oxo-2,8-dioxatricyclo[7.3.1.0,(1)(3)]trideca-1(12),3,5(13),6,9-pentaen-3-yl}phenoxy)dihydroxyoxo-lambda-sulfanylium

C18H12O10S (420.0151)


(2,6-dihydroxy-4-{4-hydroxy-7-methyl-11-oxo-2,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),3,5(13),6,9-pentaen-3-yl}phenoxy)dihydroxyoxo-λ⁶-sulfanylium is classified as a member of the 3-hydroxyflavonoids. 3-hydroxyflavonoids are flavonoids that bear one hydroxyl group at the C-3 position of the flavonoid skeleton (2,6-dihydroxy-4-{4-hydroxy-7-methyl-11-oxo-2,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),3,5(13),6,9-pentaen-3-yl}phenoxy)dihydroxyoxo-λ⁶-sulfanylium is considered to be a practically insoluble (in water) and a moderately acidic compound (2,6-dihydroxy-4-{4-hydroxy-7-methyl-11-oxo-2,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),3,5(13),6,9-pentaen-3-yl}phenoxy)dihydroxyoxo-λ⁶-sulfanylium can be found in humans.

   

1H-Perfluorooctane

1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-heptadecafluorooctane

C8HF17 (419.9807)


   

Inositol 1,3,4-triphosphate

{[2,3,5-trihydroxy-4,6-bis(phosphonooxy)cyclohexyl]oxy}phosphonic acid

C6H15O15P3 (419.9624)


   

Atrinositol

{[2,3,4-trihydroxy-5,6-bis(phosphonooxy)cyclohexyl]oxy}phosphonic acid

C6H15O15P3 (419.9624)


   

[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl] phosphono hydrogen phosphate

{[hydroxy({hydroxy[(2,3,4,5,6-pentahydroxycyclohexyl)oxy]phosphoryl}oxy)phosphoryl]oxy}phosphonic acid

C6H15O15P3 (419.9624)


   

Tiflamizole

4,5-Bis(4-fluorophenyl)-2-(1,1,2,2-tetrafluoroethanesulphonyl)-1H-imidazole

C17H10F6N2O2S (420.0367)


   

Vismodegib

2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-methanesulfonylbenzamide

C19H14Cl2N2O3S (420.0102)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XJ - Hedgehog pathway inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C188731 - Hedgehog Pathway Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor

   

4-methylthiobutyl glucosinolate

[5-(Methylsulphanyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}pentylidene]amino sulphuric acid

C12H22NO9S3 (420.0457)


4-methylthiobutyl glucosinolate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). 4-methylthiobutyl glucosinolate can be found in a number of food items such as arrowroot, ohelo berry, winged bean, and buffalo currant, which makes 4-methylthiobutyl glucosinolate a potential biomarker for the consumption of these food products.

   
   
   
   
   

Maybridge4_003054

Maybridge4_003054

C16H22FIN2S (420.0532)


   
   
   

bromotopsentin

bromotopsentin

C20H13BrN4O2 (420.0222)


An aromatic ketone that is imidazole that is substituted at positions 2 and 5 by (6-hydroxy-1H-indol-3-yl)carbonyl and 6-bromo-1H-indol-3-yl groups respectively. Isolated from Mediterranean shallow-water sponges Topsentia genetrix, and from Caribbean deep-sea sponges of the Halichondriidae family, it has antitumour and antiviral properties. Toxic to fish.

   
   

3-Bromohomofascaplysin B

3-Bromohomofascaplysin B

C21H13BrN2O3 (420.0109)


   
   

Luzonensol acetate

Luzonensol acetate

C17H26Br2O2 (420.0299)


   

5-(3,5-Dibromo-4-(3-dimethylaminopropoxy)phenyl)-4,5-dihydrooxazole-2(3H)-one

5-(3,5-Dibromo-4-(3-dimethylaminopropoxy)phenyl)-4,5-dihydrooxazole-2(3H)-one

C14H18Br2N2O3 (419.9684)


   
   

alpha-Trinositol

alpha-Trinositol

C6H15O15P3 (419.9624)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

myo-inositol 1,3,5-trisphosphate

myo-inositol 1,3,5-trisphosphate

C6H15O15P3 (419.9624)


   

Vismodegib

vismodegib(GDC-0449)

C19H14Cl2N2O3S (420.0102)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XJ - Hedgehog pathway inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C188731 - Hedgehog Pathway Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor

   

vismodegib(GDC-0449)

Vismodegib (GDC-0449)

C19H14Cl2N2O3S (420.0102)


   

D-myo-Inositol-2,4,5-triphosphate

D-myo-inositol-2,4,5-tris(hydrogen phosphate), trisodium salt

C6H15O15P3 (419.9624)


   

D-myo-Inositol-1,2,6-triphosphate

D-myo-inositol-1,2,6-tris(hydrogen phosphate), trisodium salt

C6H15O15P3 (419.9624)


   

D-myo-Inositol-1,3,5-triphosphate

D-myo-inositol-1,3,5-tris(hydrogen phosphate), trisodium salt

C6H15O15P3 (419.9624)


   

D-myo-Inositol-1,5,6-triphosphate

D-myo-inositol-1,5,6-tris(hydrogen phosphate), trisodium salt

C6H15O15P3 (419.9624)


   

D-myo-Inositol-2,3,5-triphosphate

D-myo-inositol-2,3,5-tris(dihydrogen phosphate), triammonium salt

C6H15O15P3 (419.9624)


   

D-myo-inositol-2,5,6-triphosphate

D-myo-inositol-2,5,6-tris(dihydrogen phosphate), trisodium salt

C6H15O15P3 (419.9624)


   

D-myo-Inositol-3,4,5-triphosphate

D-myo-inositol-3,4,5-tris(hydrogen phosphate), trisodium salt

C6H15O15P3 (419.9624)


   

L-myo-Inositol-1,4,5-triphosphate

3,5,6-tris(dihydrogen phosphate)D-myo-inositol

C6H15O15P3 (419.9624)


   

D-myo-Inositol-1,4,6-triphosphate

D-myo-Insitol-1,4,6-tris(dihydrogen phosphate), trisodium salt

C6H15O15P3 (419.9624)


   

D-myo-Inositol-1,3,4-triphosphate (sodium salt)

D-myo-inositol-1,3,4-tris(dihydrogen phosphate), trisodium salt

C6H15O15P3 (419.9624)


   

2-(4-(8-BROMO-3-METHYL-2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-C]QUINOLIN-1-YL)PHENYL)-2-METHYLPROPANENITRILE

2-(4-(8-BROMO-3-METHYL-2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-C]QUINOLIN-1-YL)PHENYL)-2-METHYLPROPANENITRILE

C21H17BrN4O (420.0586)


   

3-[2-(Perfluorohexyl)ethoxy]-1,2-epoxypropane

3-[2-(Perfluorohexyl)ethoxy]-1,2-epoxypropane

C11H9F13O2 (420.0395)


   

4-[(5-chloro-4-methyl-2-sulphophenyl)azo]-3-hydroxy-2-naphthoic acid

4-[(5-chloro-4-methyl-2-sulphophenyl)azo]-3-hydroxy-2-naphthoic acid

C18H13ClN2O6S (420.0183)


   

1H-Perfluorooctane

1H-Perfluorooctane

C8HF17 (419.9807)


   
   

Benzeneacetic acid, a-(2,4-dinitrophenyl)-2,4-dinitro-,ethyl ester

Benzeneacetic acid, a-(2,4-dinitrophenyl)-2,4-dinitro-,ethyl ester

C16H12N4O10 (420.0553)


   

myo-Inositol, 1,3,5-tris(dihydrogen phosphate)

myo-Inositol, 1,3,5-tris(dihydrogen phosphate)

C6H15O15P3 (419.9624)


   

1H-PERFLUORO-2,4,4-TRIMETHYLPENTANE 96

1H-PERFLUORO-2,4,4-TRIMETHYLPENTANE 96

C8HF17 (419.9807)


   
   

1,4-Bis(bromomethyl)-2-methoxy-5-(2-ethylhexyloxy)benzene

1,4-Bis(bromomethyl)-2-methoxy-5-(2-ethylhexyloxy)benzene

C17H26Br2O2 (420.0299)


   

7-Benzenesulfonyl-5-bromo-4-piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine

7-Benzenesulfonyl-5-bromo-4-piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine

C17H17BrN4O2S (420.0256)


   

Tiflamizole

Tiflamizole

C17H10F6N2O2S (420.0367)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

3-chloro-5-[(4,6-dimethoxypyrimidin-2-yl)carbamoylsulfamoyl]-1-methyl- pyrazole-4-carboxylic acid

3-chloro-5-[(4,6-dimethoxypyrimidin-2-yl)carbamoylsulfamoyl]-1-methyl- pyrazole-4-carboxylic acid

C12H13ClN6O7S (420.0255)


   

5-(4-TERT-BUTYLBENZYLTHIO)-2-(3-CHLOROBENZYLTHIO)-1,3,4-THIADIAZOLE

5-(4-TERT-BUTYLBENZYLTHIO)-2-(3-CHLOROBENZYLTHIO)-1,3,4-THIADIAZOLE

C20H21ClN2S3 (420.0555)


   

1,4-bis(bromomethyl)-2-methoxy-5-octoxybenzene

1,4-bis(bromomethyl)-2-methoxy-5-octoxybenzene

C17H26Br2O2 (420.0299)


   
   

CHLORO(CYCLOPENTADIENYL)(TRIPHENYLPHOSPHINE)NICKEL(II)

CHLORO(CYCLOPENTADIENYL)(TRIPHENYLPHOSPHINE)NICKEL(II)

C23H20ClNiP (420.0345)


   

3,3-Methylenebis(1-tert-butyl-3-imidazolium Bromide)

3,3-Methylenebis(1-tert-butyl-3-imidazolium Bromide)

C15H26Br2N4 (420.0524)


   

Bis(1-methyl-1H-indol-3-yl) perselenide

Bis(1-methyl-1H-indol-3-yl) perselenide

C18H16N2Se2 (419.9644)


   

4-chloro-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine

4-chloro-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine

C15H7ClF6N6 (420.0325)


   

Mordant Brown 49

Mordant Brown 49

C12H9N6NaO8S (420.01)


   

Pentamethylcyclopentadienylhafnium trichloride

Pentamethylcyclopentadienylhafnium trichloride

C10H15Cl3Hf (419.9705)


   

Dipotassium 2,2-biquinoline-4,4-dicarboxylate

Dipotassium 2,2-biquinoline-4,4-dicarboxylate

C20H10K2N2O4 (419.9915)


   

Chlorocitalopram, Hydrobromide

Chlorocitalopram, Hydrobromide

C20H22BrClN2O (420.0604)


   

5-chloro-2-(5-chloro-4,7-dimethyl-3-oxobenzo[b]thien-2(3H)-ylidene)-4,7-dimethylbenzo[b]thiophene-3(2H)-one

5-chloro-2-(5-chloro-4,7-dimethyl-3-oxobenzo[b]thien-2(3H)-ylidene)-4,7-dimethylbenzo[b]thiophene-3(2H)-one

C20H14Cl2O2S2 (419.9812)


   

Inositol 2,4,5-trisphosphate

Inositol 2,4,5-trisphosphate

C6H15O15P3 (419.9624)


   

Atrinositol

Atrinositol

C6H15O15P3 (419.9624)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

1D-myo-inositol 3,4,6-trisphosphate

1D-myo-inositol 3,4,6-trisphosphate

C6H15O15P3 (419.9624)


   

myo-Inositol 1,2,3-trisphosphate

myo-Inositol 1,2,3-trisphosphate

C6H15O15P3 (419.9624)


   

[(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate

[(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate

C6H15O15P3 (419.9624)


   

[(1S,2R,4S,5S)-2,3,4-Trihydroxy-5,6-diphosphonooxycyclohexyl] dihydrogen phosphate

[(1S,2R,4S,5S)-2,3,4-Trihydroxy-5,6-diphosphonooxycyclohexyl] dihydrogen phosphate

C6H15O15P3 (419.9624)


   

Astatine

Astatine

At2 (420)


   

5-(4-morpholinylsulfonyl)-N-[4-(trifluoromethoxy)phenyl]-2-furancarboxamide

5-(4-morpholinylsulfonyl)-N-[4-(trifluoromethoxy)phenyl]-2-furancarboxamide

C16H15F3N2O6S (420.0603)


   
   

(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-5,6-dihydroxy-2-methyl-4-sulfooxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-5,6-dihydroxy-2-methyl-4-sulfooxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C12H20O14S (420.0574)


   

(2S,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-5,6-dihydroxy-2-methyl-4-sulfooxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-5,6-dihydroxy-2-methyl-4-sulfooxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C12H20O14S (420.0574)


   

[(Z)-[5-methylsulfanyl-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylpentylidene]amino] sulfate

[(Z)-[5-methylsulfanyl-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylpentylidene]amino] sulfate

C12H22NO9S3- (420.0457)


   

4-Methylthiobutylglucosinolate

4-Methylthiobutylglucosinolate

C12H22NO9S3- (420.0457)


   

4-bromo-N-(1,3-dioxo-1,3,6,7-tetrahydro-2H-indeno[6,7,1-def]isoquinolin-2-yl)benzamide

4-bromo-N-(1,3-dioxo-1,3,6,7-tetrahydro-2H-indeno[6,7,1-def]isoquinolin-2-yl)benzamide

C21H13BrN2O3 (420.0109)


   

4-(4-morpholinylsulfonyl)-N-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)benzamide

4-(4-morpholinylsulfonyl)-N-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)benzamide

C17H16N4O5S2 (420.0562)


   

2,5-anhydro-3-O-(2-O-sulfo-alpha-L-idopyranuronosyl)-D-glucitol

2,5-anhydro-3-O-(2-O-sulfo-alpha-L-idopyranuronosyl)-D-glucitol

C12H20O14S (420.0574)


   

beta-D-GlcpA3S-(1->3)-2,5-anhydro-D-Glc-OH

beta-D-GlcpA3S-(1->3)-2,5-anhydro-D-Glc-OH

C12H20O14S (420.0574)


   

alpha-L-IdopA-(1->3)-2,5-anhydro-D-Glc-OH4S

alpha-L-IdopA-(1->3)-2,5-anhydro-D-Glc-OH4S

C12H20O14S (420.0574)


   

1D-Myo-inositol 1,4,5-trisphosphate

1D-Myo-inositol 1,4,5-trisphosphate

C6H15O15P3 (419.9624)


   

Inositol 1,3,4-trisphosphate

1D-Myo-inositol 1,3,4-trisphosphate

C6H15O15P3 (419.9624)


   

(2,6-Dihydroxy-4-{4-hydroxy-7-methyl-11-oxo-2,8-dioxatricyclo[7.3.1.0,(1)(3)]trideca-1(12),3,5(13),6,9-pentaen-3-yl}phenoxy)dihydroxyoxo-lambda-sulfanylium

(2,6-Dihydroxy-4-{4-hydroxy-7-methyl-11-oxo-2,8-dioxatricyclo[7.3.1.0,(1)(3)]trideca-1(12),3,5(13),6,9-pentaen-3-yl}phenoxy)dihydroxyoxo-lambda-sulfanylium

C18H12O10S (420.0151)


   

Glucoerucin(1-)

Glucoerucin(1-)

C12H22NO9S3 (420.0457)


A thia-alkylglucosinolate that has a 4-(methylsulfanyl)butyl side chain attached to the sulfonated oxime group.

   

1D-myo-Inositol 1,2,6-trisphosphate

1D-myo-Inositol 1,2,6-trisphosphate

C6H15O15P3 (419.9624)


   

[(1r,2r,3s,4s,5r,6r)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxyphosphonic acid

[(1r,2r,3s,4s,5r,6r)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxyphosphonic acid

C6H15O15P3 (419.9624)


   

n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)ethanimidic acid

n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)ethanimidic acid

C15H22Br2N2O2 (420.0048)


   

3-[4-(6-bromo-1h-indol-3-yl)-1h-imidazole-2-carbonyl]-1h-indol-6-ol

3-[4-(6-bromo-1h-indol-3-yl)-1h-imidazole-2-carbonyl]-1h-indol-6-ol

C20H13BrN4O2 (420.0222)


   

(1s,4s,5r,9r,11s,14s,15s,19r)-5,15-dihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosa-6,16-diene-2,8,12,18-tetrone

(1s,4s,5r,9r,11s,14s,15s,19r)-5,15-dihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosa-6,16-diene-2,8,12,18-tetrone

C18H16N2O6S2 (420.045)


   

(3z)-1-bromo-5-[(1r,3s)-3-bromo-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpent-3-en-2-yl acetate

(3z)-1-bromo-5-[(1r,3s)-3-bromo-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpent-3-en-2-yl acetate

C17H26Br2O2 (420.0299)


   

[(1s,2r,3r,4s,5s,6s)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxyphosphonic acid

[(1s,2r,3r,4s,5s,6s)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxyphosphonic acid

C6H15O15P3 (419.9624)


   

(2s,3z)-1-bromo-5-[(1r,3s)-3-bromo-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpent-3-en-2-yl acetate

(2s,3z)-1-bromo-5-[(1r,3s)-3-bromo-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpent-3-en-2-yl acetate

C17H26Br2O2 (420.0299)


   

(3z,6s)-3-(3,3-dichloro-2-methylprop-2-en-1-ylidene)-1,4-dimethyl-6-[(2s)-3,3,3-trichloro-2-methylpropyl]piperazine-2,5-dione

(3z,6s)-3-(3,3-dichloro-2-methylprop-2-en-1-ylidene)-1,4-dimethyl-6-[(2s)-3,3,3-trichloro-2-methylpropyl]piperazine-2,5-dione

C14H17Cl5N2O2 (419.9733)


   

21-hydroxy-9,17-dimethoxy-6-oxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁵,²⁰]henicosa-1(21),3,8,10,13,15(20),17-heptaene-2,7,12,16,19-pentone

21-hydroxy-9,17-dimethoxy-6-oxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁵,²⁰]henicosa-1(21),3,8,10,13,15(20),17-heptaene-2,7,12,16,19-pentone

C22H12O9 (420.0481)


   

[(1r,2s,3r,4r,5s,6r)-2,4,5-trihydroxy-3,6-bis(phosphonooxy)cyclohexyl]oxyphosphonic acid

[(1r,2s,3r,4r,5s,6r)-2,4,5-trihydroxy-3,6-bis(phosphonooxy)cyclohexyl]oxyphosphonic acid

C6H15O15P3 (419.9624)